Table 2.
Study patient characteristics by sex, race, and age from included implantable cardioverter–defibrillator randomized controlled trials (ICD RCTs)
| Characteristic | ICD arm (n = 3260) | Comparator arm (n = 3018)∗ | Comparator arm 2 (n = 847) |
|---|---|---|---|
| Age, y | |||
| Mean | 62.9 ± 4.0 | 63.1 ± 4.3 | NR |
| Median | 62.1 | 61.7 | 59.1 |
| Sex, % of n | |||
| Male | 77.5 | 77.5 | 77.0 |
| Female | 22.5 | 22.5 | 23.0 |
| Race, % of n | |||
| White | 75.8 | 77.1 | NR |
| Black | 17.3 | 16.9 | NR |
| Hispanic | 5.7 | 5.7 | NR |
| East Asian | 0 | 0.4 | NR |
| Southeast Asian | NR | NR | NR |
| Other† | 12.0 | 12.0 | 24.0 |
NR, not reported.
Comparator arm included either standard medical therapy, usual clinical care, treatment with amiodarone, conventional medical therapy, or ICD-CRT. Comparator arm 2 was composed of a placebo arm from Russo et al.15
“Other” includes all non-White races as reported in one study, but these were unspecified by Russo et al.15